AstraZeneca COVID-19 Vaccine Information

Disclaimer: The information on this page is intended for Healthcare Professionals only.

This medicinal product does not have a Philippine marketing authorization but has been granted emergency use authorization under Executive Order no. 121, s. 2020 by the Food and Drug Regulation of the Philippines (FDAPh) for active immunization of individuals ≥18 years old for the prevention of coronavirus disease 2019 (COVID-19). As with any new medicine in the Philippines, this product will be closely monitored to allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.

You can find out more information here (https://www.fda.gov.ph/chadox1-srecombinant-covid-19-vaccine-astrazeneca/).

Patient Information Leaflet (PIL)
Product Information

 

AstraZeneca Reporting

Report an Adverse Event
Submit a Product Quality Complaint
Request Medical Information

© AstraZeneca. All rights reserved.

Report Adverse Events

This website is intended for people seeking information on the AstraZeneca vaccine. 

exit ramp cf

azcovid-cf-text

You are now leaving azcovid-19.com

You have selected a link that will take you to a site maintained by a third party who is solely responsible for its contents.

AstraZeneca provides this link as a service to website visitors. AstraZeneca is not responsible for the privacy policy of any third party websites. We encourage you to read the privacy policy of every website you visit.

Click ‘cancel’ to return to AstraZeneca’s Vaccine site or ‘continue’ to proceed.

az-cancle-cta
Cancel
az-submit-cta
Continue